Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia.
Cai
Q
Q
Nephrology Research Unit, Mayo Clinic, Rochester, Minn. 55905.
Hodgson
S F
SF
Kao
P C
PC
Lennon
V A
VA
Klee
G G
GG
Zinsmiester
A R
AR
Kumar
R
R
D000818:Animals; D001693:Biological Transport, Active; D000242:Cyclic AMP / Q000378:metabolism; D005260:Female; D018219:Histiocytoma, Benign Fibrous / Q000150:complications / Q000473:pathology; D006801:Humans; D017674:Hypophosphatemia / Q000378:metabolism; D007668:Kidney / Q000378:metabolism*; D008875:Middle Aged; D010018:Osteomalacia / Q000209:etiology / Q000378:metabolism*; D010281:Parathyroid Hormone / Q000494:pharmacology; D010710:Phosphates / Q000037:antagonists & inhibitors*; D012983:Soft Tissue Neoplasms / Q000150:complications / Q000473:pathology; D014407:Tumor Cells, Cultured
D010281:Parathyroid Hormone; D010710:Phosphates; D000242:Cyclic AMP